Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tead1
|
ENSMUSG00000055320.10 | TEA domain family member 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_112730335_112730486 | Tead1 | 11635 | 0.185809 | 0.71 | 1.8e-09 | Click! |
chr7_112864286_112864437 | Tead1 | 24727 | 0.208499 | 0.63 | 3.2e-07 | Click! |
chr7_112697205_112697816 | Tead1 | 5812 | 0.179171 | 0.63 | 3.2e-07 | Click! |
chr7_112773782_112773933 | Tead1 | 14311 | 0.221894 | 0.62 | 4.5e-07 | Click! |
chr7_112728514_112728665 | Tead1 | 13456 | 0.180141 | 0.59 | 2.7e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_34255239_34255724 | 25.44 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
109 |
0.96 |
chr11_76120405_76120715 | 21.23 |
Vps53 |
VPS53 GARP complex subunit |
18188 |
0.16 |
chr9_63896391_63896836 | 20.01 |
Gm18541 |
predicted gene, 18541 |
1652 |
0.39 |
chr11_100970544_100970908 | 19.78 |
Cavin1 |
caveolae associated 1 |
161 |
0.93 |
chr12_79974614_79974849 | 17.30 |
Gm8275 |
predicted gene 8275 |
5120 |
0.21 |
chr5_74150094_74150338 | 15.72 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
25834 |
0.12 |
chr2_110294800_110295277 | 14.46 |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
10703 |
0.22 |
chr5_118981037_118981522 | 14.09 |
Gm43784 |
predicted gene 43784 |
15717 |
0.19 |
chr15_96744129_96744518 | 13.95 |
Gm8888 |
predicted gene 8888 |
22755 |
0.17 |
chr4_117997651_117997871 | 13.51 |
9530034E10Rik |
RIKEN cDNA 9530034E10 gene |
22725 |
0.14 |
chr4_58206387_58206947 | 13.40 |
Svep1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
21 |
0.99 |
chr2_27505528_27505834 | 13.05 |
Brd3 |
bromodomain containing 3 |
1981 |
0.25 |
chr12_15704458_15704822 | 13.04 |
Gm4804 |
predicted gene 4804 |
12960 |
0.24 |
chr14_46966253_46966532 | 13.00 |
Gm15562 |
predicted gene 15562 |
4952 |
0.15 |
chr19_38025245_38025429 | 12.95 |
Myof |
myoferlin |
18014 |
0.14 |
chr17_31746630_31747075 | 12.94 |
Gm49999 |
predicted gene, 49999 |
42652 |
0.09 |
chr9_102779494_102779836 | 12.72 |
Gm47416 |
predicted gene, 47416 |
8170 |
0.13 |
chr14_69442998_69443617 | 12.62 |
Gm16867 |
predicted gene, 16867 |
16830 |
0.11 |
chr2_141279251_141279432 | 12.58 |
Macrod2os1 |
mono-ADP ribosylhydrolase 2, opposite strand 1 |
7650 |
0.28 |
chr14_69661259_69661873 | 12.39 |
Gm27177 |
predicted gene 27177 |
16814 |
0.12 |
chr5_124509823_124510249 | 12.39 |
Rilpl1 |
Rab interacting lysosomal protein-like 1 |
4623 |
0.11 |
chr4_135828546_135828880 | 11.86 |
Gm13000 |
predicted gene 13000 |
24965 |
0.1 |
chr12_91948796_91949086 | 11.83 |
Gm21614 |
predicted gene, 21614 |
20636 |
0.16 |
chr4_156059768_156060161 | 11.80 |
Gm13648 |
predicted gene 13648 |
162 |
0.77 |
chr1_46888048_46888205 | 11.75 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
56 |
0.97 |
chr1_135836290_135836460 | 11.68 |
Tnnt2 |
troponin T2, cardiac |
11 |
0.97 |
chr1_135083513_135083778 | 11.64 |
Lgr6 |
leucine-rich repeat-containing G protein-coupled receptor 6 |
21631 |
0.11 |
chr1_152549139_152549347 | 11.62 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
3801 |
0.31 |
chr6_94203901_94204242 | 11.38 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
78954 |
0.1 |
chr6_37415105_37415455 | 11.24 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
26866 |
0.23 |
chr12_70799430_70799753 | 11.23 |
Gm40437 |
predicted gene, 40437 |
25754 |
0.16 |
chr2_132006449_132006799 | 11.21 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
14549 |
0.17 |
chr4_59292306_59292644 | 11.17 |
Susd1 |
sushi domain containing 1 |
23491 |
0.17 |
chr5_21125191_21125342 | 11.14 |
Gm18830 |
predicted gene, 18830 |
1249 |
0.35 |
chr11_68022902_68023070 | 11.14 |
Gm12303 |
predicted gene 12303 |
12724 |
0.17 |
chr7_34485450_34485601 | 10.97 |
Gm12780 |
predicted gene 12780 |
10540 |
0.16 |
chr8_122536995_122537346 | 10.83 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
14159 |
0.09 |
chr17_79451641_79451795 | 10.80 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
96627 |
0.07 |
chr7_36095842_36096014 | 10.75 |
Gm38991 |
predicted gene, 38991 |
1450 |
0.48 |
chr1_184061516_184061667 | 10.70 |
Dusp10 |
dual specificity phosphatase 10 |
27210 |
0.19 |
chr4_126495989_126496182 | 10.58 |
Gm12928 |
predicted gene 12928 |
18786 |
0.09 |
chr6_73014411_73015031 | 10.42 |
Gm20560 |
predicted gene, 20560 |
2678 |
0.26 |
chr5_31630117_31630409 | 10.41 |
Rbks |
ribokinase |
10275 |
0.11 |
chr12_76318479_76318921 | 10.34 |
Akap5 |
A kinase (PRKA) anchor protein 5 |
6191 |
0.11 |
chr10_24446302_24446457 | 10.28 |
Gm15271 |
predicted gene 15271 |
1111 |
0.57 |
chr15_6934781_6934981 | 10.28 |
Osmr |
oncostatin M receptor |
59912 |
0.13 |
chr8_26887214_26887387 | 10.25 |
2310008N11Rik |
RIKEN cDNA 2310008N11 gene |
2920 |
0.25 |
chrX_70897478_70897636 | 10.17 |
Gm6062 |
predicted gene 6062 |
80724 |
0.09 |
chr17_43407689_43407856 | 10.05 |
Adgrf5 |
adhesion G protein-coupled receptor F5 |
18284 |
0.21 |
chr9_21923967_21924400 | 10.01 |
Tmem205 |
transmembrane protein 205 |
2136 |
0.15 |
chr17_35549462_35549916 | 9.99 |
Cdsn |
corneodesmosin |
2439 |
0.12 |
chr11_54882762_54882947 | 9.89 |
Hint1 |
histidine triad nucleotide binding protein 1 |
16373 |
0.12 |
chr5_65221169_65221320 | 9.82 |
Wdr19 |
WD repeat domain 19 |
18629 |
0.16 |
chr4_43558412_43558599 | 9.71 |
Tln1 |
talin 1 |
45 |
0.93 |
chr11_94468409_94469097 | 9.71 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
4888 |
0.15 |
chr5_74161228_74161935 | 9.63 |
A330058E17Rik |
RIKEN cDNA A330058E17 gene |
14469 |
0.14 |
chr1_186015931_186016082 | 9.61 |
Gm38268 |
predicted gene, 38268 |
96367 |
0.07 |
chr8_11331735_11331978 | 9.59 |
Col4a1 |
collagen, type IV, alpha 1 |
19030 |
0.15 |
chr11_118362946_118363537 | 9.48 |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
7501 |
0.15 |
chr10_128151031_128151210 | 9.41 |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
7391 |
0.09 |
chr6_89414214_89414365 | 9.40 |
Plxna1 |
plexin A1 |
51669 |
0.12 |
chr2_163353818_163354318 | 9.33 |
Tox2 |
TOX high mobility group box family member 2 |
33690 |
0.12 |
chr1_184748943_184749140 | 9.21 |
Gm34342 |
predicted gene, 34342 |
12064 |
0.14 |
chr2_92012824_92013103 | 9.21 |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
11539 |
0.14 |
chr5_148950132_148950337 | 9.17 |
8430423G03Rik |
RIKEN cDNA 8430423G03 gene |
16 |
0.94 |
chr18_61360475_61360882 | 9.04 |
Gm25301 |
predicted gene, 25301 |
37135 |
0.11 |
chr3_152143456_152143607 | 9.04 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
3257 |
0.17 |
chr11_89672668_89672824 | 9.03 |
Ankfn1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
24099 |
0.27 |
chr8_77988376_77988637 | 9.02 |
Gm29895 |
predicted gene, 29895 |
55504 |
0.15 |
chr17_14750626_14750806 | 8.98 |
Gm23352 |
predicted gene, 23352 |
41288 |
0.14 |
chr17_31896845_31897000 | 8.96 |
Gm50000 |
predicted gene, 50000 |
2256 |
0.22 |
chr6_125323086_125323237 | 8.93 |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
1640 |
0.22 |
chr10_53324700_53325064 | 8.92 |
Pln |
phospholamban |
12785 |
0.12 |
chr9_71874816_71875171 | 8.90 |
Tcf12 |
transcription factor 12 |
9718 |
0.12 |
chr8_120860152_120860450 | 8.87 |
Gm26878 |
predicted gene, 26878 |
19905 |
0.2 |
chr2_31759665_31759990 | 8.74 |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
116 |
0.96 |
chr2_160621476_160621682 | 8.71 |
Gm14221 |
predicted gene 14221 |
1608 |
0.32 |
chr12_4285297_4285463 | 8.62 |
Ncoa1 |
nuclear receptor coactivator 1 |
10433 |
0.14 |
chr16_10664965_10665321 | 8.61 |
Gm15558 |
predicted gene 15558 |
18396 |
0.16 |
chr13_43777282_43777438 | 8.60 |
Cd83 |
CD83 antigen |
7415 |
0.21 |
chr17_47436435_47436633 | 8.59 |
AI661453 |
expressed sequence AI661453 |
81 |
0.92 |
chr10_56980964_56981278 | 8.58 |
Gm36827 |
predicted gene, 36827 |
1111 |
0.62 |
chr6_37389018_37389249 | 8.56 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
52598 |
0.15 |
chr13_113500419_113500570 | 8.52 |
4921509O07Rik |
RIKEN cDNA 4921509O07 gene |
2350 |
0.24 |
chr14_55387508_55387659 | 8.51 |
Gm49023 |
predicted gene, 49023 |
3986 |
0.16 |
chr10_76694901_76695076 | 8.49 |
Gm35608 |
predicted gene, 35608 |
10556 |
0.16 |
chr14_16328489_16328860 | 8.49 |
Gm47798 |
predicted gene, 47798 |
24163 |
0.13 |
chr1_189727337_189728664 | 8.46 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
268 |
0.92 |
chr8_36639331_36639482 | 8.46 |
Dlc1 |
deleted in liver cancer 1 |
25463 |
0.24 |
chr11_52078025_52078200 | 8.41 |
Ppp2ca |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
20569 |
0.11 |
chr9_42088051_42088202 | 8.41 |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
36171 |
0.15 |
chr1_135261026_135261195 | 8.41 |
Elf3 |
E74-like factor 3 |
2542 |
0.17 |
chr6_146979535_146979745 | 8.39 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
3157 |
0.18 |
chr17_35812833_35813649 | 8.35 |
Ier3 |
immediate early response 3 |
8443 |
0.07 |
chr16_91846429_91846756 | 8.34 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
3964 |
0.21 |
chr8_122661148_122661378 | 8.26 |
Cbfa2t3 |
CBFA2/RUNX1 translocation partner 3 |
14797 |
0.09 |
chr2_6099009_6099213 | 8.24 |
Proser2 |
proline and serine rich 2 |
31028 |
0.13 |
chr4_123699563_123699729 | 8.23 |
Gm12922 |
predicted gene 12922 |
10381 |
0.13 |
chr10_13210007_13210663 | 8.22 |
Gm47402 |
predicted gene, 47402 |
5109 |
0.21 |
chr8_8812577_8812737 | 8.18 |
Gm44622 |
predicted gene 44622 |
76687 |
0.07 |
chr4_139580628_139581320 | 8.18 |
Iffo2 |
intermediate filament family orphan 2 |
6254 |
0.15 |
chr3_121559557_121559708 | 8.17 |
Slc44a3 |
solute carrier family 44, member 3 |
27228 |
0.14 |
chr2_170147589_170148059 | 8.17 |
Zfp217 |
zinc finger protein 217 |
279 |
0.95 |
chr13_72419489_72419940 | 8.15 |
Rpl9-ps4 |
ribosomal protein L9, pseudogene 4 |
35626 |
0.14 |
chr16_44695627_44695867 | 8.13 |
Nepro |
nucleolus and neural progenitor protein |
28554 |
0.16 |
chr5_147601560_147601711 | 8.05 |
Flt1 |
FMS-like tyrosine kinase 1 |
13607 |
0.21 |
chr11_11949064_11949279 | 8.04 |
Grb10 |
growth factor receptor bound protein 10 |
2841 |
0.28 |
chr18_54476905_54477056 | 8.00 |
Gm50361 |
predicted gene, 50361 |
215 |
0.95 |
chr11_88528624_88528775 | 7.98 |
Msi2 |
musashi RNA-binding protein 2 |
61448 |
0.12 |
chr6_34313457_34313608 | 7.93 |
Akr1b3 |
aldo-keto reductase family 1, member B3 (aldose reductase) |
3898 |
0.19 |
chr1_190899107_190899511 | 7.92 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
408 |
0.84 |
chr7_45744505_45744676 | 7.90 |
Sult2b1 |
sulfotransferase family, cytosolic, 2B, member 1 |
1844 |
0.13 |
chr9_63657266_63657436 | 7.90 |
Smad3 |
SMAD family member 3 |
9196 |
0.2 |
chr11_100138941_100139108 | 7.89 |
Krt15 |
keratin 15 |
3096 |
0.11 |
chr10_12694819_12695171 | 7.87 |
Utrn |
utrophin |
6133 |
0.3 |
chr11_120684807_120684958 | 7.86 |
Aspscr1 |
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
1811 |
0.13 |
chr5_115524119_115524337 | 7.86 |
Pxn |
paxillin |
3923 |
0.11 |
chr18_5396168_5396377 | 7.85 |
Gm50065 |
predicted gene, 50065 |
25790 |
0.18 |
chr7_121778700_121778876 | 7.85 |
Scnn1g |
sodium channel, nonvoltage-gated 1 gamma |
44309 |
0.12 |
chr14_54966795_54967354 | 7.84 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
147 |
0.84 |
chr13_60007626_60007984 | 7.83 |
A530065N20Rik |
RIKEN cDNA A530046M15 gene |
21906 |
0.16 |
chr17_73060473_73060992 | 7.83 |
Gm30420 |
predicted gene, 30420 |
31654 |
0.17 |
chr9_116872914_116873407 | 7.81 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
50341 |
0.18 |
chr14_21903554_21904173 | 7.77 |
4931407E12Rik |
RIKEN cDNA 4931407E12 gene |
14097 |
0.14 |
chr10_63541782_63541976 | 7.76 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
32627 |
0.19 |
chr17_31889924_31890110 | 7.75 |
Gm50000 |
predicted gene, 50000 |
9161 |
0.14 |
chr6_135067129_135067353 | 7.75 |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
1590 |
0.32 |
chr8_36528292_36528784 | 7.74 |
Trmt9b |
tRNA methyltransferase 9B |
23049 |
0.2 |
chr6_89344742_89345287 | 7.72 |
Gm44207 |
predicted gene, 44207 |
126 |
0.95 |
chr5_138979980_138980131 | 7.69 |
Pdgfa |
platelet derived growth factor, alpha |
14226 |
0.17 |
chr12_90946204_90946419 | 7.69 |
Gm47688 |
predicted gene, 47688 |
7929 |
0.18 |
chr16_90016108_90016386 | 7.69 |
Tiam1 |
T cell lymphoma invasion and metastasis 1 |
36167 |
0.18 |
chr4_123227810_123228007 | 7.63 |
Heyl |
hairy/enhancer-of-split related with YRPW motif-like |
5648 |
0.12 |
chr17_35720310_35720775 | 7.60 |
Ddr1 |
discoidin domain receptor family, member 1 |
15921 |
0.07 |
chr16_23239665_23239933 | 7.60 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
13778 |
0.12 |
chr4_139259576_139259773 | 7.58 |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
26291 |
0.11 |
chr2_163809927_163810078 | 7.55 |
Ccn5 |
cellular communication network factor 5 |
10859 |
0.18 |
chr17_31944023_31944187 | 7.49 |
Gm17572 |
predicted gene, 17572 |
6429 |
0.16 |
chr11_63169008_63169159 | 7.48 |
B430319H21Rik |
RIKEN cDNA B430319H21 gene |
4831 |
0.23 |
chr5_23920044_23920195 | 7.46 |
Fam126a |
family with sequence similarity 126, member A |
2785 |
0.2 |
chr2_27636894_27637066 | 7.46 |
Rxra |
retinoid X receptor alpha |
39460 |
0.16 |
chr5_140383662_140383903 | 7.45 |
Snx8 |
sorting nexin 8 |
1049 |
0.43 |
chr18_60293263_60293414 | 7.44 |
F830016B08Rik |
RIKEN cDNA F830016B08 gene |
42 |
0.97 |
chr7_89386750_89387115 | 7.42 |
Gm44996 |
predicted gene 44996 |
4391 |
0.17 |
chr16_85133471_85133764 | 7.38 |
Gm49226 |
predicted gene, 49226 |
15212 |
0.18 |
chr5_142545135_142545286 | 7.38 |
Radil |
Ras association and DIL domains |
182 |
0.93 |
chr11_65667485_65667686 | 7.37 |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
29429 |
0.19 |
chr12_79859643_79860074 | 7.37 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
64875 |
0.11 |
chr5_36069536_36069852 | 7.37 |
Afap1 |
actin filament associated protein 1 |
82689 |
0.09 |
chr7_127932703_127932876 | 7.36 |
Prss36 |
protease, serine 36 |
2640 |
0.1 |
chr5_117363394_117363667 | 7.34 |
Wsb2 |
WD repeat and SOCS box-containing 2 |
8 |
0.96 |
chr15_97773076_97773402 | 7.31 |
Rapgef3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
5267 |
0.13 |
chr13_32924664_32924815 | 7.31 |
Gm11382 |
predicted pseudogene 11382 |
13952 |
0.13 |
chr2_27206188_27206812 | 7.30 |
Sardh |
sarcosine dehydrogenase |
3437 |
0.17 |
chr7_129876601_129876770 | 7.22 |
Gm44778 |
predicted gene 44778 |
43639 |
0.18 |
chr8_94300862_94301044 | 7.21 |
Nup93 |
nucleoporin 93 |
4946 |
0.13 |
chr8_125174848_125175247 | 7.21 |
Gm16237 |
predicted gene 16237 |
52276 |
0.14 |
chr4_42336460_42336671 | 7.20 |
Fam205a3 |
family with sequence similarity 205, member A3 |
18293 |
0.11 |
chr16_45838163_45838314 | 7.20 |
Phldb2 |
pleckstrin homology like domain, family B, member 2 |
5996 |
0.23 |
chr19_10176937_10177104 | 7.19 |
Gm50359 |
predicted gene, 50359 |
859 |
0.43 |
chr2_68431057_68431343 | 7.18 |
Stk39 |
serine/threonine kinase 39 |
40740 |
0.15 |
chr7_28721276_28721463 | 7.17 |
Fbxo17 |
F-box protein 17 |
4496 |
0.1 |
chr6_148318766_148318917 | 7.15 |
Rps4l |
ribosomal protein S4-like |
35815 |
0.12 |
chr11_4060990_4061145 | 7.14 |
Sec14l3 |
SEC14-like lipid binding 3 |
3774 |
0.13 |
chr6_93257695_93257846 | 7.10 |
Gm44220 |
predicted gene, 44220 |
16050 |
0.23 |
chr6_119196404_119196860 | 7.07 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
214 |
0.94 |
chr5_32066147_32066336 | 7.06 |
Babam2 |
BRISC and BRCA1 A complex member 2 |
13456 |
0.19 |
chr17_46273936_46274087 | 7.06 |
Tjap1 |
tight junction associated protein 1 |
1856 |
0.19 |
chr11_95071308_95071615 | 7.05 |
Itga3 |
integrin alpha 3 |
2263 |
0.21 |
chr7_110297264_110297888 | 7.04 |
Gm9132 |
predicted gene 9132 |
4425 |
0.2 |
chr7_68313170_68313416 | 7.04 |
4930405G09Rik |
RIKEN cDNA 4930405G09 gene |
3739 |
0.16 |
chr8_12774807_12775329 | 7.01 |
Atp11a |
ATPase, class VI, type 11A |
17999 |
0.15 |
chr5_32353438_32353589 | 6.99 |
Plb1 |
phospholipase B1 |
56 |
0.95 |
chr2_73654410_73654564 | 6.99 |
Chn1 |
chimerin 1 |
571 |
0.73 |
chr1_133695909_133696268 | 6.97 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
5793 |
0.14 |
chr4_42509837_42509989 | 6.95 |
Fam205a2 |
family with sequence similarity 205, member A2 |
18262 |
0.13 |
chr6_120146726_120146909 | 6.94 |
Gm25327 |
predicted gene, 25327 |
3067 |
0.28 |
chr11_76374871_76375078 | 6.94 |
Nxn |
nucleoredoxin |
24094 |
0.16 |
chr1_16996761_16996912 | 6.92 |
Jph1 |
junctophilin 1 |
7383 |
0.24 |
chr16_25417962_25418220 | 6.92 |
Gm18896 |
predicted gene, 18896 |
25182 |
0.26 |
chr4_141286951_141287172 | 6.91 |
Gm13056 |
predicted gene 13056 |
8622 |
0.11 |
chr19_6278181_6278879 | 6.90 |
Ehd1 |
EH-domain containing 1 |
1605 |
0.16 |
chr1_87394695_87394846 | 6.86 |
Kcnj13 |
potassium inwardly-rectifying channel, subfamily J, member 13 |
41 |
0.96 |
chr16_50753698_50753981 | 6.86 |
Dubr |
Dppa2 upstream binding RNA |
21066 |
0.17 |
chr9_117192681_117192891 | 6.86 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
58811 |
0.13 |
chr6_38771414_38771565 | 6.86 |
Hipk2 |
homeodomain interacting protein kinase 2 |
28229 |
0.2 |
chr6_100732315_100732977 | 6.86 |
Gm15576 |
predicted gene 15576 |
6412 |
0.18 |
chr5_77155017_77155198 | 6.85 |
Chaer1 |
cardiac hypertrophy associated epigenetic regulator 1 |
14855 |
0.13 |
chr4_106144456_106144607 | 6.82 |
Hspd1-ps4 |
heat shock protein 1 (chaperonin), pseudogene 4 |
6753 |
0.18 |
chr10_75465605_75465756 | 6.81 |
Gm48158 |
predicted gene, 48158 |
17712 |
0.12 |
chr11_72406403_72406587 | 6.79 |
Smtnl2 |
smoothelin-like 2 |
3387 |
0.16 |
chr10_4325732_4325897 | 6.78 |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
8731 |
0.19 |
chr6_115924946_115925106 | 6.77 |
Rho |
rhodopsin |
6722 |
0.12 |
chr2_131902867_131903054 | 6.74 |
Lamr1-ps1 |
laminin receptor 1 (ribosomal protein SA), pseudogene 1 |
1126 |
0.38 |
chr13_53193848_53194064 | 6.73 |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
81702 |
0.09 |
chr9_20975440_20975967 | 6.72 |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
1001 |
0.32 |
chr3_145734950_145735101 | 6.67 |
Gm43408 |
predicted gene 43408 |
4141 |
0.23 |
chr7_45784749_45786509 | 6.65 |
Lmtk3 |
lemur tyrosine kinase 3 |
119 |
0.87 |
chr18_56688485_56688641 | 6.65 |
Lmnb1 |
lamin B1 |
19250 |
0.15 |
chr10_125961290_125962183 | 6.62 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4432 |
0.33 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 19.4 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
2.8 | 11.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.6 | 7.7 | GO:0007525 | somatic muscle development(GO:0007525) |
2.2 | 8.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
2.2 | 8.8 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
1.8 | 10.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.8 | 12.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.7 | 5.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.6 | 8.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.6 | 4.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.5 | 7.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.4 | 4.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.4 | 2.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.3 | 5.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.3 | 5.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.3 | 11.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.3 | 2.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.3 | 3.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 3.8 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.3 | 3.8 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.3 | 3.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.2 | 3.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.2 | 4.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.2 | 3.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.2 | 3.5 | GO:0040031 | snRNA modification(GO:0040031) |
1.1 | 2.2 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.1 | 5.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 3.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.1 | 3.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.1 | 3.3 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.1 | 3.2 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.1 | 4.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
1.1 | 3.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.1 | 5.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.1 | 2.1 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
1.0 | 3.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.0 | 23.9 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
1.0 | 3.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 3.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.0 | 3.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.0 | 2.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.9 | 2.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.9 | 6.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.9 | 2.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.9 | 1.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.9 | 4.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 7.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.9 | 5.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.9 | 0.9 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.9 | 10.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.9 | 2.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.8 | 1.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.8 | 5.0 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.8 | 2.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.8 | 2.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 0.8 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.8 | 1.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 2.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 4.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.8 | 1.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.8 | 1.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.8 | 4.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.8 | 4.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.8 | 5.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.8 | 2.3 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.8 | 1.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.8 | 3.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.8 | 5.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.7 | 2.2 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.7 | 3.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.7 | 2.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 3.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.7 | 2.9 | GO:0046909 | intermembrane transport(GO:0046909) |
0.7 | 2.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.7 | 2.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 7.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.7 | 2.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.7 | 2.7 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 10.0 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.7 | 6.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.7 | 1.3 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.7 | 5.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.7 | 2.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 1.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.6 | 1.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 2.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 3.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.6 | 1.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 2.4 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.6 | 2.9 | GO:1902338 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) |
0.6 | 1.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.6 | 1.7 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.6 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 3.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.6 | 1.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.6 | 7.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 3.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.6 | 1.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 6.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.5 | 3.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 3.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 1.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 0.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 2.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.5 | 2.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 2.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.5 | 2.1 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.5 | 1.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 4.1 | GO:0060068 | vagina development(GO:0060068) |
0.5 | 2.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 1.5 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 1.5 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 1.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.5 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 2.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 1.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 1.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 2.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.5 | 0.5 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.5 | 1.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.5 | 1.4 | GO:2000321 | regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.5 | 2.9 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.5 | 1.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 2.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 1.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.5 | 2.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 2.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 1.9 | GO:0061055 | myotome development(GO:0061055) |
0.5 | 1.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.5 | 1.9 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 0.9 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 0.9 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.5 | 1.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 1.8 | GO:0046959 | habituation(GO:0046959) |
0.5 | 0.5 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.5 | 0.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 1.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 3.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 1.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.5 | 1.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 2.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.5 | 1.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 0.4 | GO:0003133 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.4 | 1.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 1.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 0.9 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.4 | 1.7 | GO:0018214 | protein carboxylation(GO:0018214) |
0.4 | 1.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 0.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 2.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 1.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 6.0 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.4 | 1.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 1.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 1.3 | GO:0002434 | immune complex clearance(GO:0002434) |
0.4 | 1.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 2.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 1.2 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.4 | 2.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 1.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.4 | 1.2 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.4 | 1.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.4 | 1.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 1.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.4 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.4 | 1.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 2.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 1.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 0.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.4 | 1.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 1.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 0.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 4.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 0.8 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 1.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.4 | 3.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 0.8 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.4 | 1.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 1.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 1.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 1.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.4 | 1.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 1.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 2.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.4 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 2.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.4 | 3.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.4 | 0.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.4 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 2.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 1.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.4 | 0.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.4 | 0.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.4 | 3.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 1.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 0.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.4 | 1.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 1.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 3.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 0.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 1.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.7 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.3 | 2.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 2.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 5.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 1.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 1.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 2.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 0.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 2.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.3 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 0.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 1.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 2.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 2.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.3 | 0.6 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.3 | 1.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.9 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 2.8 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 0.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 1.3 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 0.9 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 0.3 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 0.3 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.3 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 0.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 0.6 | GO:0060066 | oviduct development(GO:0060066) |
0.3 | 4.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.3 | 6.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.3 | 2.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 3.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 2.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 1.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 0.3 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.3 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.6 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 3.3 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 1.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 0.3 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.3 | 2.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 0.9 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 0.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 0.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.3 | 1.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 1.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.9 | GO:0061727 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 1.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.6 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.3 | 0.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.3 | 0.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.7 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.3 | 0.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 0.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 4.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.3 | 0.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 0.6 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 0.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 1.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 2.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 1.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 1.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 0.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 1.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.3 | 0.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 1.6 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.3 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.3 | 5.9 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 1.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 0.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 1.6 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 0.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.3 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 0.5 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.3 | 1.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 1.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 0.5 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.3 | 1.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.3 | 0.3 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.3 | 0.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 1.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.5 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.3 | 0.5 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.3 | 5.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 1.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.5 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 0.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 1.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.7 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 0.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 2.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 1.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 1.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 2.6 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.2 | 0.9 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.2 | 0.5 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.2 | 0.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 2.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 1.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 2.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 2.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 2.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.2 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.9 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.7 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.4 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.2 | 0.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 1.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.2 | 1.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0010873 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) |
0.2 | 1.6 | GO:0097531 | mast cell migration(GO:0097531) |
0.2 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.2 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.2 | 0.4 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.9 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.2 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 0.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.7 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.2 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.2 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 2.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 2.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 1.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 1.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 1.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 8.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 1.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 1.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 3.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 1.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 3.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 6.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.2 | 0.6 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 1.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 2.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.4 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.6 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.2 | 1.2 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 0.8 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 1.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 1.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 4.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 2.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 1.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 1.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.6 | GO:0009130 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 1.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 1.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.4 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.2 | 0.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 2.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 5.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.2 | GO:0032736 | positive regulation of interleukin-13 production(GO:0032736) |
0.2 | 1.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.4 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 1.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 1.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 1.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 0.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.2 | 1.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.2 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.2 | 3.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 8.3 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 1.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.2 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.4 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.5 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.7 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 5.5 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.2 | 1.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 1.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 1.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.7 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.5 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 1.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.2 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.2 | 1.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 4.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 1.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 1.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 3.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.3 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.8 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.3 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 1.9 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.5 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.3 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 0.3 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 0.8 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 3.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 1.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 1.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) purine nucleoside monophosphate catabolic process(GO:0009128) |
0.2 | 0.3 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.2 | 0.5 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.2 | 0.6 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.2 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 4.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 1.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 1.1 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 1.1 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 1.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 1.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.6 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 5.1 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.7 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 1.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.3 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 1.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.3 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.4 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 2.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 2.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.8 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.3 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.3 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.7 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 3.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.5 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.7 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.7 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 2.3 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 2.5 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 2.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 2.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.7 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 3.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 5.3 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.1 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.1 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 1.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.1 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.1 | 0.5 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.3 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 1.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 1.5 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.2 | GO:0086067 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.1 | GO:0032347 | negative regulation of aldosterone metabolic process(GO:0032345) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.1 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.8 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.2 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 1.0 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 1.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.6 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.8 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.9 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 1.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 1.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 1.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 0.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 1.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.5 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.4 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:1901301 | cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 2.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.6 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.9 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.8 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 2.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 1.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 2.1 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.9 | GO:0055024 | regulation of cardiac muscle tissue development(GO:0055024) |
0.1 | 0.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.7 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.1 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.4 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 1.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.7 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.7 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.1 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.2 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.3 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.5 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 0.5 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.1 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 0.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.4 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.2 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.1 | 0.1 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.1 | 0.6 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.2 | GO:0003283 | atrial septum development(GO:0003283) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.4 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.6 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.1 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 2.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 1.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.4 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.1 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.1 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 2.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 1.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.5 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.1 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 0.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 0.1 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 1.0 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 1.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0016114 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.3 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.3 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 1.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 3.4 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 1.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.1 | 0.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.1 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.1 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.3 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.6 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 2.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.7 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 1.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.1 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.8 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.5 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.7 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.1 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.3 | GO:0045429 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.0 | 0.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.3 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0019627 | urea metabolic process(GO:0019627) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.0 | 0.0 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.0 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.6 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.4 | GO:0001947 | heart looping(GO:0001947) |
0.0 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.0 | 0.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.0 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.0 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.8 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.0 | 0.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.6 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.0 | 0.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.4 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.5 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.0 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.4 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.3 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.0 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.1 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.2 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0035404 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.0 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.0 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.0 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.0 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.1 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.0 | 0.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.0 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 24.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.4 | 19.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
2.1 | 16.9 | GO:0005861 | troponin complex(GO:0005861) |
1.5 | 4.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.4 | 8.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.4 | 4.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.3 | 3.8 | GO:0097513 | myosin II filament(GO:0097513) |
1.1 | 3.2 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 3.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 5.6 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 3.5 | GO:1990745 | EARP complex(GO:1990745) |
0.9 | 4.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 2.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.8 | 3.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.7 | 6.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 11.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.6 | 2.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 1.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.6 | 3.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 1.2 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 3.5 | GO:0032982 | myosin filament(GO:0032982) |
0.6 | 8.1 | GO:0036379 | myofilament(GO:0036379) |
0.6 | 4.6 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 8.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 1.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 2.1 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 28.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 2.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 3.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 6.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.5 | GO:0031430 | M band(GO:0031430) |
0.5 | 2.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 1.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 1.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 3.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 4.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 2.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 5.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 0.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 1.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.4 | 1.5 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 4.6 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 2.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 1.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 1.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 0.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 2.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 2.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 4.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.3 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 0.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 1.4 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 2.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 3.3 | GO:0043034 | costamere(GO:0043034) |
0.3 | 1.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 5.1 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 6.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 2.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 10.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 2.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 1.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.3 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 16.7 | GO:0031674 | I band(GO:0031674) |
0.2 | 1.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 4.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 4.2 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 6.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 3.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 2.0 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 3.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 14.6 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 1.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.5 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 4.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 0.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.3 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 7.6 | GO:0005844 | polysome(GO:0005844) |
0.2 | 6.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.2 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 1.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 9.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 6.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 3.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 9.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 2.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 1.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 1.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 35.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 4.0 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 1.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 4.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 3.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 3.7 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 2.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 4.5 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.1 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 6.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 2.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 3.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 5.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 2.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 8.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 1.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 3.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 24.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 11.3 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 5.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 2.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 2.9 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 4.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.9 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 4.2 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 3.4 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.6 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 2.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.6 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.1 | GO:0044440 | endosomal part(GO:0044440) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 3.2 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.5 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.7 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.0 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 1.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 3.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) |
0.0 | 2.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 3.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 25.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.7 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 1.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 0.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.1 | GO:0030172 | troponin C binding(GO:0030172) |
3.2 | 9.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.9 | 5.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.9 | 22.3 | GO:0017166 | vinculin binding(GO:0017166) |
1.8 | 19.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.6 | 6.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.6 | 8.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.4 | 4.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 7.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 5.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.1 | 3.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 6.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.0 | 4.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.0 | 2.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 3.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.9 | 5.7 | GO:0043495 | protein anchor(GO:0043495) |
0.9 | 3.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.9 | 2.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.8 | 2.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 14.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.8 | 3.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 1.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.8 | 1.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.8 | 7.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 9.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 4.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.8 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 9.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.7 | 11.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 2.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 4.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.7 | 7.3 | GO:0048185 | activin binding(GO:0048185) |
0.7 | 2.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 1.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 1.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 1.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 6.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.6 | 4.8 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 2.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 6.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 1.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.6 | 7.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 1.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 12.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 2.8 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 2.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 4.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 1.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.6 | 5.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.5 | 3.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 1.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 2.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.5 | 1.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 3.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 4.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 6.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 1.5 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 3.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.5 | 1.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 1.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 1.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 2.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 6.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 2.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 9.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 1.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.4 | 1.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 3.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 0.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 2.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 1.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 2.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 2.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 5.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 2.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 1.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 2.3 | GO:0033265 | choline binding(GO:0033265) |
0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 5.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 3.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 2.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 2.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 6.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 0.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 1.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 1.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 1.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 2.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 1.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 6.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 3.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 2.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 0.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 2.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 2.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 0.6 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.3 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 5.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 3.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 4.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 1.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 2.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 0.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.3 | 1.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 0.8 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 1.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 0.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.3 | 3.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.3 | 0.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 2.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 2.7 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.3 | 2.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 1.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.3 | 1.3 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 2.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.8 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 1.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 1.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 4.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 3.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.5 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.2 | 1.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.7 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 2.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 1.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 2.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 5.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.6 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 2.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 2.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 2.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.4 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 3.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 2.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 2.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 1.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 0.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 1.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 2.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 5.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 1.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 2.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 7.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 1.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 6.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 4.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 5.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 5.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 1.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 5.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 2.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 6.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 2.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 3.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 1.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.6 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.9 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 4.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 3.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 12.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 10.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.0 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 1.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.9 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 1.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 5.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 4.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 3.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 4.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 2.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 10.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 1.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.2 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 3.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 1.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 2.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.0 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 2.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 2.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.1 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.1 | 0.6 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 13.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.4 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 1.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 11.6 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 2.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 1.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 2.4 | GO:0015297 | antiporter activity(GO:0015297) |
0.1 | 1.6 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.6 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.1 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 1.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 1.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 1.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 1.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 1.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.6 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.8 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0018563 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.2 | GO:0034865 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 2.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 1.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 6.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 1.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 2.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.0 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.0 | GO:0032557 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 3.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 5.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.0 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.0 | GO:0018502 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.0 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0052635 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.7 | 2.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.7 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 1.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 7.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 16.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.6 | 15.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 2.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 1.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 9.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 3.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 6.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 9.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 8.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 1.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 8.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 4.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 10.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 1.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 1.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 2.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 5.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 7.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 2.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 8.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 7.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 3.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 8.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 19.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 7.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 3.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 2.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 4.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 2.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 9.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 5.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 4.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 1.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 2.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 5.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 1.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 5.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 1.7 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 3.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 5.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 17.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 20.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 12.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 2.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 7.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 52.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.3 | 29.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 6.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.8 | 11.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 1.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 6.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 7.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 6.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 1.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 4.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.5 | 7.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 3.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 10.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 9.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 4.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 5.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 3.0 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.3 | 8.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 2.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 14.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 1.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 5.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 1.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 5.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 1.7 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 4.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 1.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 0.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 2.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 4.9 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 2.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 18.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 3.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 1.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 2.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 0.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 6.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.7 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 4.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 5.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 6.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 3.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 8.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 3.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 3.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 5.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 5.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.1 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 3.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 3.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 2.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.5 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 4.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 1.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |